These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7852517

  • 1. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
    Matera C, Freda PU, Ferin M, Wardlaw SL.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
    [Abstract] [Full Text] [Related]

  • 2. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB, Nippoldt TB, Kletter GB, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [Abstract] [Full Text] [Related]

  • 3. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
    de Wit W, Schoute E, Schoemaker J.
    J Clin Endocrinol Metab; 1995 May; 80(5):1739-42. PubMed ID: 7745028
    [Abstract] [Full Text] [Related]

  • 4. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F, De Leo V, Nappi C, Facchinetti F, Montemagno U, Brambilla F, Genazzani AR.
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [Abstract] [Full Text] [Related]

  • 5. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I, Ambrosi F, Giammartino C, Fedeli L, Mannarelli C, Filipponi P.
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [Abstract] [Full Text] [Related]

  • 6. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F, Sandoval JL, Salinas E, Franco-Rodriguez VA, Méndez I, Ulloa-Aguirre A.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [Abstract] [Full Text] [Related]

  • 7. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B, Young J, Brailly S, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [Abstract] [Full Text] [Related]

  • 8. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [Abstract] [Full Text] [Related]

  • 9. In pubertal girls, naloxone fails to reverse the suppression of luteinizing hormone secretion by estradiol.
    Cemeroglu AP, Kletter GB, Guo W, Brown MB, Kelch RP, Marshall JC, Padmanabhan V, Foster CM.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3501-6. PubMed ID: 9768654
    [Abstract] [Full Text] [Related]

  • 10. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
    Fox SR, Hoefer MT, Bartke A, Smith MS.
    Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
    [Abstract] [Full Text] [Related]

  • 11. Sustained effects of opioid antagonism during the normal human luteal phase.
    Gindoff PR, Jewelewicz R, Hembree W, Wardlaw S, Ferin M.
    J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A, Beitins IZ, Merriam GR, McArthur JW, Zervas NT, Ridgway EC.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [Abstract] [Full Text] [Related]

  • 13. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 14. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 15. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C, Ambrosi F, Pelicci G, Pagliacci MC, Fedeli L, Nicoletti I.
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [Abstract] [Full Text] [Related]

  • 16. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
    Kletter GB, Padmanabhan V, Beitins IZ, Marshall JC, Kelch RP, Foster CM.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
    [Abstract] [Full Text] [Related]

  • 17. Nocturnal melatonin and luteinizing hormone rhythms in women with hyperprolactinemic amenorrhea.
    Luboshitzky R, Lavi S, Thuma I, Lavie P.
    J Pineal Res; 1996 Mar; 20(2):72-8. PubMed ID: 8815190
    [Abstract] [Full Text] [Related]

  • 18. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 19. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG, Mortola JF, Yen SS.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [Abstract] [Full Text] [Related]

  • 20. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM, Randolph JF, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.